MCID: CRD229
MIFTS: 39

Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Categories: Genetic diseases, Rare diseases, Reproductive diseases, Endocrine diseases, Cardiovascular diseases

Aliases & Classifications for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

MalaCards integrated aliases for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

Name: Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism 57 75
Malouf Syndrome 57 76 53 59 75 13 73
Najjar Syndrome 57 53 59 75 55 73
Dilated Cardiomyopathy-Hypergonadotropic Hypogonadism Syndrome 53 59 29 6
Cardiogenital Syndrome 57 53 59 75
Genital Anomaly with Cardiomyopathy 57 53 75
Cardiomyopathy with Primary Testicular Failure 57 75
Cardiomyopathy, Congestive, with Hypergonadotropic Hypogonadism 57
Cardiomyopathy Congestive with Hypergonadotropic Hypogonadism 75
Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism 53
Cardiomyopathy, Dilated, with Premature Ovarian Failure 57
Cardiomyopathy Dilated with Premature Ovarian Failure 75
Cmdhh 75

Characteristics:

Orphanet epidemiological data:

59
dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal;

OMIM:

57
Inheritance:
autosomal dominant


HPO:

32
cardiomyopathy, dilated, with hypergonadotropic hypogonadism:
Inheritance autosomal recessive inheritance autosomal dominant inheritance


Classifications:



Summaries for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

NIH Rare Diseases : 53 Dilated cardiomyopathy with hypergonadotropic hypogonadism (DCMHH) is a condition that primarily affects the heart and gonads (male testes or female ovaries). It is characterized by a disease of the heart muscle (dilated cardiomyopathy) and little or no production of sex hormones due to a problem with the pituitary gland or hypothalamus (hypergonadotropic hypogonadism). Other symptoms might include: characteristic facial features, intellectual disability, mild skeletal anomalies, and abnormalities of the metabolic system. Some cases of DCMHH are caused by mutations in the LMNA gene. Both autosomal dominant and autosomal recessive inheritance patterns have been described. Although there is no specific treatment or cure for DCMHH, there are ways to manage the symptoms. A team of doctors or specialists is often needed to figure out the treatment options for each person.

MalaCards based summary : Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism, also known as malouf syndrome, is related to crigler-najjar syndrome, type i and crigler-najjar syndrome, type ii. An important gene associated with Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism is LMNA (Lamin A/C). The drugs Liver Extracts and Ornithine have been mentioned in the context of this disorder. Affiliated tissues include testes, heart and ovary, and related phenotypes are polycystic ovaries and wide nasal bridge

UniProtKB/Swiss-Prot : 75 Cardiomyopathy, dilated, with hypergonadotropic hypogonadism: A disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia.

Wikipedia : 76 Malouf syndrome (also known as \"congestive cardiomyopathy-hypergonadotropic hypogonadism syndrome\") is... more...

Description from OMIM: 212112

Related Diseases for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Diseases related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 25)
# Related Disease Score Top Affiliating Genes
1 crigler-najjar syndrome, type i 12.7
2 crigler-najjar syndrome, type ii 12.6
3 seow najjar syndrome 12.0
4 gilbert syndrome 11.4
5 hutchinson-gilford progeria syndrome 11.2
6 type i 10.6
7 kernicterus 10.1
8 dilated cardiomyopathy 10.0
9 hepatitis 10.0
10 cholestasis 9.9
11 hypogonadism 9.9
12 hemophilia a 9.8
13 aging 9.8
14 beta-thalassemia 9.8
15 thalassemia 9.8
16 hereditary spherocytosis 9.8
17 acute cholangitis 9.8
18 intrahepatic cholestasis 9.8
19 neonatal jaundice 9.8
20 influenza 9.8
21 cholangitis 9.8
22 hemophilia 9.8
23 congenital nonhemolytic jaundice 9.8
24 encephalopathy 9.8
25 trehalase deficiency 9.0 LMNA UGT1A1

Graphical network of the top 20 diseases related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:



Diseases related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Symptoms & Phenotypes for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Face:
retrognathia

Muscle Soft Tissue:
lipodystrophy

Chest External Features:
sloping shoulders

Head And Neck Eyes:
ptosis, bilateral (in some patients)

Cardiovascular Heart:
cardiomyopathy, dilated
mitral valve insufficiency
tricuspid valve insufficiency

Genitourinary Internal Genitalia Female:
ovarian failure, premature
ovarian dysgenesis

Skeletal Hands:
acrogeric appearance (prominent veins and lack of subcutaneous tissue)

Laboratory Abnormalities:
elevated serum levels of follicle stimulating hormone (fsh)
elevated serum levels of luteinizing hormone (lh)

Endocrine Features:
hypergonadotropic hypogonadism

Neurologic Central Nervous System:
mental retardation (in some patients)

Chest Ribs Sternum Clavicles And Scapulae:
clavicular hypoplasia

Head And Neck Nose:
narrow, beaked nose

GenitourinaryInternal GenitaliaMale:
testicular failure

Skeletal:
osteopenia/osteoporosis

Skeletal Feet:
acrogeric appearance (prominent veins and lack of subcutaneous tissue)


Clinical features from OMIM:

212112

Human phenotypes related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

59 32 (show all 13)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 polycystic ovaries 59 32 hallmark (90%) Very frequent (99-80%) HP:0000147
2 wide nasal bridge 59 32 hallmark (90%) Very frequent (99-80%) HP:0000431
3 ptosis 59 32 occasional (7.5%) Very frequent (99-80%) HP:0000508
4 hypergonadotropic hypogonadism 59 32 hallmark (90%) Very frequent (99-80%) HP:0000815
5 precocious puberty 59 32 hallmark (90%) Very frequent (99-80%) HP:0000826
6 dilated cardiomyopathy 59 32 hallmark (90%) Very frequent (99-80%) HP:0001644
7 aplasia of the phalanges of the 3rd toe 59 32 hallmark (90%) Very frequent (99-80%) HP:0100362
8 retrognathia 32 HP:0000278
9 short clavicles 32 HP:0000894
10 intellectual disability 32 occasional (7.5%) HP:0001249
11 mitral regurgitation 32 HP:0001653
12 lipodystrophy 32 HP:0009125
13 down-sloping shoulders 32 HP:0200021

GenomeRNAi Phenotypes related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-119 8.92 LMNA
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-34 8.92 LMNA UGT1A1
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 8.92 LMNA

Drugs & Therapeutics for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Drugs for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Liver Extracts Phase 1, Phase 2
2
Ornithine Approved, Nutraceutical Phase 1 70-26-8, 3184-13-2 6262
3
Acetylcholine Approved Not Applicable 51-84-3 187
4
Orlistat Approved, Investigational Not Applicable 96829-58-2 3034010
5 abobotulinumtoxinA Not Applicable
6 Botulinum Toxins Not Applicable
7 Botulinum Toxins, Type A Not Applicable
8 Cholinergic Agents Not Applicable
9 Neuromuscular Agents Not Applicable
10 Neurotransmitter Agents Not Applicable
11 onabotulinumtoxinA Not Applicable
12 Peripheral Nervous System Agents Not Applicable
13 Anti-Obesity Agents Not Applicable
14
Bilirubin Not Applicable 635-65-4 5280352

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) Completed NCT01765283 Phase 1, Phase 2
2 Gene Therapy for Severe Crigler Najjar Syndrome Recruiting NCT03466463 Phase 1, Phase 2
3 Gene Transfer Clinical Study in Crigler-Najjar Syndrome Recruiting NCT03223194 Phase 1, Phase 2
4 Hepatocyte Transplantation for Liver Based Metabolic Disorders Suspended NCT01345578 Phase 1 human hepatocyte transplantation
5 Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome Unknown status NCT00564707 Not Applicable
6 Immunity Against AAV in Crigler Najjar Patient Completed NCT02302690
7 Orlistat Treatment of Crigler-Najjar Disease Completed NCT00461799 Not Applicable orlistat
8 Clinical Assessment Study in Crigler-Najjar Syndrome Recruiting NCT03078881
9 New Phototherapy Device to Treat Patients With Crigler-Najjar Disease Recruiting NCT02356978 Not Applicable
10 Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001) Active, not recruiting NCT02051049
11 HepaStem Long-Term Safety Registry Not yet recruiting NCT03343756

Search NIH Clinical Center for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Genetic Tests for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Genetic tests related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

# Genetic test Affiliating Genes
1 Dilated Cardiomyopathy-Hypergonadotropic Hypogonadism Syndrome 29 LMNA

Anatomical Context for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

MalaCards organs/tissues related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

41
Testes, Heart, Ovary, Pituitary, Hypothalamus, Skin, Bone

Publications for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Articles related to Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

# Title Authors Year
1
Malouf syndrome with hypergonadotropic hypogonadism and cardiomyopathy: two-case report and literature review. ( 25544917 )
2014
2
Dilated cardiomyopathy and ovarian dysgenesis in a patient with Malouf syndrome: a case report. ( 24008991 )
2013
3
Case of ovarian dysgenesis and dilated cardiomyopathy supports existence of Malouf syndrome. ( 1488988 )
1992

Variations for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

UniProtKB/Swiss-Prot genetic disease variations for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

75
# Symbol AA change Variation ID SNP ID
1 LMNA p.Ala57Pro VAR_017656 rs28928903
2 LMNA p.Leu59Arg VAR_064055 rs58922911

ClinVar genetic disease variations for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 LMNA NM_170707.3(LMNA): c.169G> C (p.Ala57Pro) single nucleotide variant Pathogenic rs28928903 GRCh37 Chromosome 1, 156084878: 156084878
2 LMNA NM_170707.3(LMNA): c.169G> C (p.Ala57Pro) single nucleotide variant Pathogenic rs28928903 GRCh38 Chromosome 1, 156115087: 156115087
3 LMNA NM_170707.3(LMNA): c.176T> G (p.Leu59Arg) single nucleotide variant Pathogenic rs58922911 GRCh37 Chromosome 1, 156084885: 156084885
4 LMNA NM_170707.3(LMNA): c.176T> G (p.Leu59Arg) single nucleotide variant Pathogenic rs58922911 GRCh38 Chromosome 1, 156115094: 156115094
5 LMNA NM_005572.3(LMNA): c.1003C> T (p.Arg335Trp) single nucleotide variant Pathogenic/Likely pathogenic rs386134243 GRCh37 Chromosome 1, 156105758: 156105758
6 LMNA NM_005572.3(LMNA): c.1003C> T (p.Arg335Trp) single nucleotide variant Pathogenic/Likely pathogenic rs386134243 GRCh38 Chromosome 1, 156135967: 156135967

Expression for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Search GEO for disease gene expression data for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism.

Pathways for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

GO Terms for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

Sources for Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....